UKCA Marking for Surgical Instruments: 2026 Guide

Does a box of CE-marked Mayo scissors still sell legally into an English hospital in 2026? Yes. Does that mean you can ignore UKCA? No — and the reasons are worth getting right before your next UK tender, because the deadlines are real, the paperwork is different, and a few details work differently from the EU.

This guide is written for two readers: UK distributors and NHS buyers checking what their overseas supplier should provide, and manufacturers outside the UK deciding when and how to move to UKCA marking for surgical instruments.

The short version

Note the dates in that table. In February 2026 the MHRA consulted on proposals that included recognising EU MDR CE marking indefinitely and moving the MDD deadline to 31 December 2028. Until those proposals are formally adopted in law, plan against the dates above. Check the MHRA’s own guidance on gov.uk before you lock a regulatory budget.

Why UKCA exists at all

Before Brexit, the UK applied EU device law and CE marking was the only route. After the transition period ended on 31 December 2020, Great Britain kept the EU directive-era rules, frozen into the UK MDR 2002, and created its own conformity mark: UKCA (UK Conformity Assessed).

The EU then moved on to the Medical Device Regulation (EU MDR 2017/745). Great Britain did not adopt it. So today three regimes touch a single box of instruments heading to the UK:

• UK MDR 2002 — the legal baseline in Great Britain, with UKCA as its native mark
• EU MDD — the old directive, still honoured in GB for legacy CE certificates until mid-2028
• EU MDR — the current EU law, honoured in GB until mid-2030 under current legislation

Northern Ireland sits apart. Under the Windsor Framework it applies EU rules, so a device sold in Belfast needs CE marking (or CE plus UKNI where a UK notified body was used).

How surgical instruments are classified in Great Britain

This is where the UK and EU genuinely diverge, and where many guides get it wrong.

Under EU MDR, a reusable surgical instrument — a Kelly forceps, a Metzenbaum scissor, a Langenbeck retractor — is Class Ir. That “r” matters. It means a notified body must review the reprocessing aspects: cleaning, disinfection, sterilisation and the limit on reuse. A Class Ir instrument cannot be pure self-certification in the EU any more.

The UK MDR 2002 is built on the old directive, and the old directive has no Class Ir. Under UK rules, a reusable surgical instrument is ordinary Class I. For a standard non-sterile, non-measuring instrument, the manufacturer can self-declare conformity. No UK Approved Body is needed.

In practice this means a GB route for basic reusable instruments can be simpler than the EU route. It does not mean “no work”. Self-declaration still requires a full technical file, a declaration of conformity, registration and a functioning post-market system.

A note on “measuring”

Graduated instruments sit in a grey zone. A uterine sound with centimetre markings, or a periodontal probe with millimetre bands, can be argued either way depending on the intended purpose stated in the labelling. If the markings are there for the clinician to take a measurement that guides treatment, assume the measuring route applies and get advice.

What the manufacturer actually has to produce

For a Class I reusable instrument under the UK MDR 2002, expect to have the following in place before the first UKCA-marked box ships.

Technical documentation

• Device description, intended purpose and variants (sizes, patterns, jaw types)
• Materials, with steel grades — typically AISI 410, 420 or 440A for cutting and clamping instruments, and 304 or 316L for holloware
• Applicable standards: ISO 7153-1 for instrument materials, ISO 13485 for the quality system, ISO 14971 for risk management, and product standards such as ISO 7151 or ISO 7741 where relevant
• Risk management file to ISO 14971
• Validated reprocessing instructions, usually referencing ISO 17664-1
• Labelling and instructions for use
• Clinical evaluation proportionate to a well-established, low-risk device
• Post-market surveillance plan

Much of this overlaps with an EU technical file. A manufacturer already holding CE documentation is not starting from zero. The work is mainly mapping the file to the UK essential requirements and adding UK-specific pieces such as the UKRP and MHRA registration.

Declaration of conformity

A signed UK declaration, referencing the UK MDR 2002 rather than EU law, listing the devices covered, the classification and the standards applied.

Labelling

The UKCA mark must be at least 5 mm high (unless a smaller size is justified for a very small device), legible and indelible. The UKRP’s name and address must accompany the device as MHRA guidance requires. Laser marking the instrument itself with a catalogue number and lot is good practice for traceability, though the UKCA mark is normally on the packaging and labelling rather than etched on a 14 cm Adson forceps.

The UK Responsible Person

A manufacturer based outside the UK cannot place devices on the GB market directly. It must appoint a UK Responsible Person — a UK-established company that acts on its behalf.

The UKRP’s duties are not a formality:

• Register the manufacturer’s devices with the MHRA
• Hold, or have access to, the technical documentation and declaration of conformity
• Provide information and samples to the MHRA on request
• Cooperate on corrective and preventive actions
• Pass on complaints and incident reports to the manufacturer
• End the mandate if the manufacturer acts contrary to its obligations, and inform the MHRA

Many UK distributors offer UKRP services. Some specialist regulatory firms do too. For a buyer, the practical check is simple: ask your supplier who their UKRP is, and confirm the devices you are buying appear on the MHRA public register.

Registration with the MHRA

All medical devices placed on the GB market must be registered with the MHRA, whether they carry CE or UKCA marking. For a non-UK manufacturer, the UKRP does this. Registration is done through the MHRA’s online device registration system and a fee is charged per registration.

A common trap: a distributor imports CE-marked instruments for years, assuming CE alone is enough. It is not. Registration is a separate obligation. If the instruments are not registered, the distributor is selling unregistered devices regardless of the CE mark on the box.

Post-market surveillance — the 2025 change

The biggest shift in GB device law since Brexit is not the UKCA mark itself. It is post-market surveillance. Updated GB requirements, made in 2024, came into force on 16 June 2025. They apply to devices on the GB market whether they carry UKCA or CE marking.

For a Class I instrument manufacturer this means, in outline:

• A documented PMS system and plan, proportionate to the risk class
• Collecting and analysing complaints, returns and field data
• Periodic reporting, with the depth and frequency scaled to the device class
• Reporting serious incidents to the MHRA within defined deadlines — generally 15 days, and much faster for deaths, serious deterioration in health or a serious public health threat
• Trend reporting where non-serious incidents increase significantly

For instrument makers, typical post-market signals include tip fracture on fine forceps, ratchet failure on needle holders, corrosion after reprocessing, and tungsten carbide insert detachment. A good PMS system tracks these by pattern and lot, so a problem in one batch of 18 cm Mayo-Hegar needle holders can be traced and contained.

Converting an existing CE file for Great Britain

Most instrument makers selling to the UK already hold CE documentation. The fastest route to UKCA is to adapt that file, not to write a new one. Here is the sequence we would follow for a family of reusable clamping instruments — say, a range of Kelly, Crile and Rochester-Pean forceps in 14 to 24 cm lengths.

1. Re-check the classification. Confirm every variant is Class I under the UK rules. Pull out anything sterile or graduated for separate treatment.
2. Map the essential requirements. The EU MDR file is built around the General Safety and Performance Requirements. The UK file must reference the Essential Requirements of the UK MDR 2002. The content is similar; the cross-reference table is not. Build a new checklist rather than relabelling the old one.
3. Check the standards list. GB uses “designated standards”, which largely mirror the EU harmonised list but are published separately. Confirm the versions you cite are designated in GB.
4. Update labelling artwork. Add the UKCA mark and UKRP details. If the same box will also go to the EU, the label can carry both CE and UKCA, with the EU authorised representative and UKRP both shown.
5. Write the UK declaration of conformity. Separate from the EU declaration, referencing UK law.
6. Appoint the UKRP and register. Sign a written mandate first, then register device by device.
7. Extend the PMS plan. Add UK incident reporting routes and timelines, and make sure UK complaints reach the manufacturer quickly through the UKRP.

For a well-organised manufacturer this is weeks of work, not months. The slowest step is usually the essential requirements mapping, because it touches every section of the file. Dual-labelled packaging is worth the effort for exporters: one box, one stock code, two markets.

Timeline: when do you actually need UKCA?

Because of the pending consultation, some manufacturers are delaying UKCA work in the hope that EU MDR CE will be recognised indefinitely. That may prove right. But a UK tender closing in 2029 may ask what the supplier’s plan is, and “we are waiting” is a weak answer. A sensible middle path is to keep the technical file in a state that can be converted quickly, appoint the UKRP now, and register now.

What NHS and private buyers should ask a supplier

1. What marking do the instruments carry — CE under MDD, CE under EU MDR, UKCA, or a combination?
2. For CE: under which legislation, and when does any certificate expire?
3. Who is your UK Responsible Person? Please provide their name and address.
4. Are these specific product codes registered with the MHRA?
5. Can you provide the declaration of conformity and the ISO 13485 certificate?
6. What are your reprocessing instructions, and are they validated?
7. How do you handle complaints and incident reports from UK users?

The same questions work in tender clarification rounds. A supplier that answers all seven with documents, not promises, is unlikely to cause a compliance problem halfway through a contract. For the wider document set an importer needs, see our import documentation guide, and for markets that ask for proof of home-country sale, our certificate of free sale guide.

Common mistakes we see

Assuming UKCA marking for surgical instruments works in the EU. It does not. A UKCA-only device cannot be sold in Ireland, France or Northern Ireland.

Treating Northern Ireland as part of the GB route. It is not. Belfast hospitals need CE.

Copying the EU Class Ir logic into the UK file. It is not wrong to have notified body evidence on reprocessing, and it strengthens the file. But it is not the UK legal classification, and the declaration should state the UK class correctly.

Forgetting registration. CE or UKCA marking without MHRA registration is non-compliant.

Letting the UKRP drift. If the distributor acting as UKRP changes, the registration and labelling must change too.

Where Fizza Surgical fits

We manufacture reusable instruments in Sialkot under an ISO 13485 quality system and supply CE-marked products. For UK buyers, we can provide our declaration, certificates and reprocessing instructions, and work with your UK Responsible Person on registration. See our certifications or browse the surgical instrument catalogue.